1	HIV-1	HIV-1	_	_	_	_	_	_	_
2	envelope	envelope	_	_	_	_	_	_	_
3	glycoproteins	glycoprotein	_	_	_	_	_	_	_
4	induce	induce	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	activated	activate	_	_	_	_	_	_	_
8	protein-1	protein-1	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	CD4+	cd4+	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	[	[	_	_	_	_	_	_	_
14	published	publish	_	_	_	_	_	_	_
15	erratum	erratum	_	_	_	_	_	_	_
16	appears	appear	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	J	J	_	_	_	_	_	_	_
19	Biol	Biol	_	_	_	_	_	_	_
20	Chem	Chem	_	_	_	_	_	_	_
21	1995	1995	_	_	_	_	_	_	_
22	Dec	Dec	_	_	_	_	_	_	_
23	1;270(48):29038	1;270(48):29038	_	_	_	_	_	_	_
24	]	]	_	_	_	_	_	_	_
25	Activation	activation	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	CD4	CD4	_	_	_	_	_	_	_
28	positive	positive	_	_	_	_	_	_	_
29	T	t	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	is	be	_	_	_	_	_	_	_
32	a	a	_	_	_	_	_	_	_
33	primary	primary	_	_	_	_	_	_	_
34	requirement	requirement	_	_	_	_	_	_	_
35	for	for	_	_	_	_	_	_	_
36	human	human	_	_	_	_	_	_	_
37	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
38	virus	virus	_	_	_	_	_	_	_
39	(	(	_	_	_	_	_	_	_
40	HIV	HIV	_	_	_	_	_	_	_
41	)	)	_	_	_	_	_	_	_
42	entry	entry	_	_	_	_	_	_	_
43	,	,	_	_	_	_	_	_	_
44	efficient	efficient	_	_	_	_	_	_	_
45	HIV	HIV	_	_	_	_	_	_	_
46	replication	replication	_	_	_	_	_	_	_
47	,	,	_	_	_	_	_	_	_
48	and	and	_	_	_	_	_	_	_
49	progression	progression	_	_	_	_	_	_	_
50	to	to	_	_	_	_	_	_	_
51	AIDS	AIDS	_	_	_	_	_	_	_
52	,	,	_	_	_	_	_	_	_
53	Utilizing	utilize	_	_	_	_	_	_	_
54	CD4	cd4	_	_	_	_	_	_	_
55	positive	positive	_	_	_	_	_	_	_
56	T	t	_	_	_	_	_	_	_
57	cell	cell	_	_	_	_	_	_	_
58	lines	line	_	_	_	_	_	_	_
59	and	and	_	_	_	_	_	_	_
60	purified	purify	_	_	_	_	_	_	_
61	T	t	_	_	_	_	_	_	_
62	cells	cell	_	_	_	_	_	_	_
63	from	from	_	_	_	_	_	_	_
64	normal	normal	_	_	_	_	_	_	_
65	individuals	individual	_	_	_	_	_	_	_
66	,	,	_	_	_	_	_	_	_
67	we	we	_	_	_	_	_	_	_
68	have	have	_	_	_	_	_	_	_
69	demonstrated	demonstrate	_	_	_	_	_	_	_
70	that	that	_	_	_	_	_	_	_
71	native	native	_	_	_	_	_	_	_
72	envelope	envelope	_	_	_	_	_	_	_
73	glycoproteins	glycoprotein	_	_	_	_	_	_	_
74	of	of	_	_	_	_	_	_	_
75	HIV	HIV	_	_	_	_	_	_	_
76	,	,	_	_	_	_	_	_	_
77	gp	gp	_	_	_	_	_	_	_
78	160	160	_	_	_	_	_	_	_
79	,	,	_	_	_	_	_	_	_
80	can	can	_	_	_	_	_	_	_
81	induce	induce	_	_	_	_	_	_	_
82	activation	activation	_	_	_	_	_	_	_
83	of	of	_	_	_	_	_	_	_
84	transcription	transcription	_	_	_	_	_	_	_
85	factor	factor	_	_	_	_	_	_	_
86	,	,	_	_	_	_	_	_	_
87	activated	activate	_	_	_	_	_	_	_
88	protein-1	protein-1	_	_	_	_	_	_	_
89	(	(	_	_	_	_	_	_	_
90	AP-1	ap-1	_	_	_	_	_	_	_
91	)	)	_	_	_	_	_	_	_
92	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	stimulatory	stimulatory	_	_	_	_	_	_	_
3	effects	effect	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	gp160	gp160	_	_	_	_	_	_	_
6	are	be	_	_	_	_	_	_	_
7	mediated	mediate	_	_	_	_	_	_	_
8	through	through	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	CD4	cd4	_	_	_	_	_	_	_
11	molecule	molecule	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	since	since	_	_	_	_	_	_	_
14	treatment	treatment	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	gp160	gp160	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	soluble	soluble	_	_	_	_	_	_	_
19	CD4-IgG	CD4-IgG	_	_	_	_	_	_	_
20	abrogates	abrogate	_	_	_	_	_	_	_
21	its	its	_	_	_	_	_	_	_
22	activity	activity	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	CD4	cd4	_	_	_	_	_	_	_
26	negative	negative	_	_	_	_	_	_	_
27	T	t	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	lines	line	_	_	_	_	_	_	_
30	fail	fail	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	be	be	_	_	_	_	_	_	_
33	stimulated	stimulate	_	_	_	_	_	_	_
34	with	with	_	_	_	_	_	_	_
35	gp160	gp160	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Immunoprecipitation	Immunoprecipitation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	gp	gp	_	_	_	_	_	_	_
5	160-induced	160-induced	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	extracts	extract	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	polyclonal	polyclonal	_	_	_	_	_	_	_
10	antibodies	antibody	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	Fos	Fos	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	Jun	Jun	_	_	_	_	_	_	_
15	proteins	protein	_	_	_	_	_	_	_
16	indicates	indicate	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	AP-1	ap-1	_	_	_	_	_	_	_
19	complex	complex	_	_	_	_	_	_	_
20	is	be	_	_	_	_	_	_	_
21	comprised	comprise	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	members	member	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	these	these	_	_	_	_	_	_	_
26	family	family	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	proteins	protein	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	gp160-induced	gp160-induced	_	_	_	_	_	_	_
3	AP-1	ap-1	_	_	_	_	_	_	_
4	complex	complex	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	dependent	dependent	_	_	_	_	_	_	_
7	upon	upon	_	_	_	_	_	_	_
8	protein	protein	_	_	_	_	_	_	_
9	tyrosine	tyrosine	_	_	_	_	_	_	_
10	phosphorylation	phosphorylation	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	synthesis-independent	synthesis-independent	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	can	can	_	_	_	_	_	_	_
4	also	also	_	_	_	_	_	_	_
5	be	be	_	_	_	_	_	_	_
6	abolished	abolish	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	inhibitors	inhibitor	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	protein	protein	_	_	_	_	_	_	_
11	kinase	kinase	_	_	_	_	_	_	_
12	C	C	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	but	but	_	_	_	_	_	_	_
15	it	it	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	unaffected	unaffected	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	calcium	calcium	_	_	_	_	_	_	_
20	channel	channel	_	_	_	_	_	_	_
21	blocker	blocker	_	_	_	_	_	_	_
22	or	or	_	_	_	_	_	_	_
23	cyclosporine	cyclosporine	_	_	_	_	_	_	_
24	A	a	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	gp160	gp160	_	_	_	_	_	_	_
3	treatment	treatment	_	_	_	_	_	_	_
4	adversely	adversely	_	_	_	_	_	_	_
5	affects	affect	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	functional	functional	_	_	_	_	_	_	_
8	capabilities	capability	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	:	:	_	_	_	_	_	_	_
13	pre-treatment	pre-treatment	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	CD4+	cd4+	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	gp160	gp160	_	_	_	_	_	_	_
20	for	for	_	_	_	_	_	_	_
21	4	4	_	_	_	_	_	_	_
22	h	h	_	_	_	_	_	_	_
23	at	at	_	_	_	_	_	_	_
24	37	37	_	_	_	_	_	_	_
25	degrees	degree	_	_	_	_	_	_	_
26	C	C	_	_	_	_	_	_	_
27	inhibited	inhibit	_	_	_	_	_	_	_
28	anti-CD3-induced	anti-cd3-induced	_	_	_	_	_	_	_
29	interleukin-2	interleukin-2	_	_	_	_	_	_	_
30	secretion	secretion	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Effects	Effect	_	_	_	_	_	_	_
2	similar	similar	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	gp160	gp160	_	_	_	_	_	_	_
5	were	be	_	_	_	_	_	_	_
6	seen	see	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	anti-CD4	anti-cd4	_	_	_	_	_	_	_
9	mAb	mab	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	aberrant	aberrant	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	AP-1	ap-1	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	gp160	gp160	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	CD4	cd4	_	_	_	_	_	_	_
10	positive	positive	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	could	could	_	_	_	_	_	_	_
14	result	result	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	up-regulation	up-regulation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	cytokines	cytokine	_	_	_	_	_	_	_
19	containing	contain	_	_	_	_	_	_	_
20	AP-1	ap-1	_	_	_	_	_	_	_
21	sites	site	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	e.g.	e.g.	_	_	_	_	_	_	_
24	interleukin-3	interleukin-3	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	granulocyte	granulocyte	_	_	_	_	_	_	_
27	macrophage	macrophage	_	_	_	_	_	_	_
28	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
29	factor	factor	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	concurrently	concurrently	_	_	_	_	_	_	_
33	lead	lead	_	_	_	_	_	_	_
34	to	to	_	_	_	_	_	_	_
35	T	t	_	_	_	_	_	_	_
36	cell	cell	_	_	_	_	_	_	_
37	unresponsiveness	unresponsiveness	_	_	_	_	_	_	_
38	by	by	_	_	_	_	_	_	_
39	inhibiting	inhibit	_	_	_	_	_	_	_
40	interleukin-2	interleukin-2	_	_	_	_	_	_	_
41	secretion	secretion	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

